Body mass index increase and weight gain among people living with HIV-1 initiated on single-tablet darunavir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide in the United States-Reference-Cited by-同舟云学术

Body mass index increase and weight gain among people living with HIV-1 initiated on single-tablet darunavir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide in the United States

Published:2021-12-07 Issue:2 Volume:38 Page:287-298
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Emond Bruno¹,Rossi Carmine¹,Côté-Sergent Aurélie¹,Bookhart Brahim²,Anderson David²,Lefebvre Patrick¹,Lafeuille Marie-Hélène¹,Donga Prina²

Affiliation:

1. Analysis Group, Inc, Montréal, Canada

2. Janssen Scientific Affairs, LLC, Titusville, NJ, USA

Funder

Janssen Scientific Affairs

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.2007006

Reference61 articles.

1. Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2014–2018. HIV surveillance supplemental report 2020;25(No. 1). [cited 2021 Oct 28]. Available from: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html

2. The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex

3. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study

4. Prevention of HIV-1 Infection with Early Antiretroviral Therapy

5. Updates of Lifetime Costs of Care and Quality-of-Life Estimates for HIV-Infected Persons in the United States

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Human Immunodeficiency Virus on Women in the United States;Nursing Clinics of North America;2024-06

2. A lipid index for risk of hyperlipidemia caused by anti-retroviral drugs;Antiviral Research;2024-03

3. Biktarvy for the treatment of HIV infection: Progress and prospects;Biochemical Pharmacology;2023-11

4. Weight and metabolic changes among virally suppressed people with HIV who switched to co-formulated bictegravir/emtricitabine/tenofovir alafenamide;Journal of Global Antimicrobial Resistance;2023-11

5. Weight gain following switch to integrase inhibitors from non-nucleoside reverse transcriptase or protease inhibitors in people living with HIV in the United States: analyses of electronic medical records and prescription claims;Current Medical Research and Opinion;2023-08-10